Why UST

UST VISION 2025

PROUDUST

Training USTians with pride by promotinga creative educational environment

UNIQUE
DIFFERENT
PROFESSIONAL
Excellent
Secure world-leading educational competitiveness

Discovering creative talent and to become real USTians
Establishment of UST21 education system

Entrepreneur
Become a university with industry-academia-research integration

Strengthening the cooperation between UST-GFRIs-corporations
Strengthen the cooperation between GFRIs
Support business start-ups with GFRI-based technologies

Global
Establish global status as a national research university

Improving brand value
Improving cooperation network

Smart
Establish creative knowledge management system

Providing creative educational environment by applying cutting-edge technology
Improving management effectiveness

Introduce

This specialty is offered to train students as experts in this professional field. After they have completed the courses of study required, they will be able to conduct research on and development of commercial products such as pharmaceuticals, foods, etc. using bioengineering technology. Their work will then also promote further growth and industrialization of the bioengineering field. To evaluate the efficacy and safety of new products, existing disciplines such as toxicology, toxicological pathology, safety pharmacology, laboratory animal science, environmental toxicology, and risk assessment must be applied. However, current training systems in the existing universities cannot produce appropriately trained scientists to fulfill the current requirements of the industry. Therefore, this specialty is expected to contribute greatly to the national supply of trained human resources, and thus to growth in industries concerned with the safety and efficacy of many products to which humans, animals and the environment are exposed. This will predictably lead predictably to increases in the quality of our national science and technology, as well as to our national welfare. The major objectives in preparing students for careers in this specialty will include training in the following subject areas, at minimum: 1. Fundamentals of toxicology, environmental toxicology, toxicological pathology, safety pharmacology, laboratory animal science, and related disciplines contributing to the assessment of efficacy and safety. 2. Basic skills and knowledge necessary to evaluate the physiologic and pharmacologic activities of new pharmaceutical candidates, allowing students to clearly understand their modes of actions on each organ or tissue. 3. Recent technologies and trends in the development of new pharmaceuticals, and how to evaluate efficacy of new pharmaceutical candidates. 4. Review of recently developed Living Modified Organism (LMO) products, the technologies required and used to evaluate their efficacy and their risks to humans and the environment. 5. Knowledge and skills necessary to evaluate and analyze the occupational health and safety of workers in the industry. 6. Administration and management of bioassays for the safety and efficacy of new products, to include Good Laboratory Practices (GLP) required to register new products. Careful analysis of test outcomes and incorporation of the test results in detailed reports are also included.

Current status of student majors

Current status of student majors
Enrolled Students 10 Average age of new students in master course 24.6
Students on leave - Average age of new students in doctor course 34.57
Completion Students 4 Average age of new students in integrative course 28.25
Master Graduates 17 Average graduation period in master course 2.27
Doctoral Graduates 5 Average graduation period in doctor course 4.82
International Students 4 Average graduation period in inegrative course 5.99

Student Research Performance

Search
소속전공 정보
소속전공 제공합니다.
Year Field of Research Journal Research
2014 Journal Toxicological Research Inhalation of carbon black nanoparticles aggravates pulmonary inflammation in mice
2014 Journal Environmental Toxicology 피라미 간에서 benzo(a)pyrene에 의해 유도되는 Cytochrome P450 system 발현과 DNA adduct 형성에 관한 연구
2012 Journal BioChip Journal Gene expression profiles of TM4 mouse Sertoli cells after 1,3-dinitrobenzene exposure and analysis of genes related to tight junction signaling pathways
2011 Journal Molecular & Cellular Toxicology Differential gene expression induced by aphthalene in two human cell line, HepG2 and HL-60.
2011 Journal Molecular & Cellular Toxicology Differential gene expression profiling in human promyelocytic leukemia cells treated with benzene and ethylbenzene.
2011 Journal Toxicological Research Dose-response Effects of Bleomycin on Inflammation and Pulmonary Fibrosis in Mice
2011 Journal Toxicological Reserch Dose-response Effectsof Bleomycin in Inflammation and Pulmonary Fibrosis in Mice
2011 Journal Molecular & Cellular Toxicology Functional gene analysis to identify potential markers induced by benzene in two different cell lines, HepG2 and HL-60
2011 Journal Toxicology Gene expression profiles of human promyelocytic leukemia cell lines exposed to volatile organic compounds
2011 Journal Toxicology Induction of apoptosis in human leukemia cells through the production of reactive oxygen species and activation of HMOX1 and Noxa by benzene, toluene, and o-xylene
2011 Journal Toxicological Research LC50 Determination of tert-Butyl Acetate using a Nose Only Inhalation Exposure in Rats
2011 Journal Toxicological Reserch LC50 Determination of tert-Butyl Acetate using a Nose-Only Inhalation Exposure in Rats
2011 Journal Toxicological Reserch Standardization of Bronchoalveolar Lavage Method Based on Suction Frequency Number and Lavage Fraction Number Using Rats
2011 Journal Toxicological Research Standardization of Broncholaveolar Lavage Method Based on Suction Frequency Number and Lavage Fraction Number Using Rats
2011 Journal Laboratory Animal Research The incidence rate and severity of orthotopic lung cancer in an animal model depends on the number of A549 cells and transplantation period
2010 Journal Toxicology letters 1,3-Dinitrobenzene induces apoptosis in TM4 mouse Sertoli cells: Involvement of the c-Jun N-terminal kinase (JNK) MAPK pathway